Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11925629 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Raghava Reddy Kethiri, Purushottam Dewang +2 more | 2024-03-12 |
| 11103491 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Raghava Reddy Kethiri, Purushottam Dewang +2 more | 2021-08-31 |
| 10912779 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Scott K. Thompson, Roger Smith, Tyler M. John, Vijay Kumar Nyavanandi, Subramanya Hosahalli +4 more | 2021-02-09 |
| 10751332 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Raghava Reddy Kethiri, Purushottam Dewang +2 more | 2020-08-25 |
| 10471051 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Raghava Reddy Kethiri, Purushottam Dewang +4 more | 2019-11-12 |
| 10226468 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Scott K. Thompson, Roger Smith, Tyler M. John, Vijay Kumar Nyavanandi, Subramanya Hoshalli +4 more | 2019-03-12 |
| 10188654 | Uses of pyrimido-pyridazinones to treat cancer | Sandeep Gupta, Roger Smith | 2019-01-29 |
| 9896445 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Raghava Reddy Kethiri, Purushottam Dewang +4 more | 2018-02-20 |
| 9757382 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Scott K. Thompson, Roger Smith, Tyler M. John, Vijay Kumar Nyavanandi, Hosahalli Subramanya +4 more | 2017-09-12 |
| 9499495 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Scott K. Thompson, Roger Smith, Tyler M. John, Vijay Kumar Nyavanandi, Hosahalli Subramanya +4 more | 2016-11-22 |